Warren Averett Asset Management, LLC Repligen Corp Transaction History
Warren Averett Asset Management, LLC
- $7.99 Billion
- Q1 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 20,432 shares of RGEN stock, worth $2.58 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
20,432Holding current value
$2.58 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
494Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$955 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$955 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$641 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$213 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$211 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....